Schwartz R D, Jackson J A, Weigert D, Skolnick P, Paul S M
J Neurosci. 1985 Nov;5(11):2963-70. doi: 10.1523/JNEUROSCI.05-11-02963.1985.
Membrane chloride (Cl-) permeability was studied in a novel subcellular brain preparation, the synaptoneurosome. Using a radioactive tracer exchange technique, Cl- transport was determined by measuring 36Cl- efflux from rat cerebral cortical synaptoneurosomes. Barbiturates increased 36Cl- efflux in a dose-dependent manner with the following relative order of potency: 5-(1,3-dimethylbutyl)-5-ethyl barbituric acid ((-)-DMBB) greater than pentobarbital greater than secobarbital greater than (+)-DMBB greater than hexobarbital greater than amobarbital greater than mephobarbital. Phenobarbital and barbital were virtually inactive. A good correlation was observed between the potencies of these barbiturates in stimulating 36Cl- efflux and their anesthetic potencies in mice (r = 0.90, p less than 0.01) and their abilities to enhance [3H] diazepam binding to brain membranes (r = 0.77, p less than 0.05). The effect of pentobarbital in enhancing 36Cl- efflux was reversed by the gamma-aminobutyric acid (GABA) antagonists picrotoxin and bicuculline. Picrotoxin and bicuculline both decreased 36Cl- efflux in the absence of pentobarbital, suggesting the presence of endogenous GABA. Incubation of synaptoneurosomes with 4,4'-di-isothiocyano- or dinitro-2,2'-disulfonic acid stilbene, inhibitors of anion transport, also decreased both basal and pentobarbital-induced 36Cl- efflux. Pentobarbital (500 microM) was most effective in inducing 36Cl- efflux in the cerebellum, hippocampus, and cortex (23.7, 23.6, and 22.5%, respectively), and was less effective in stimulating 36Cl- efflux in the striatum (15.1%) and pons-medulla (6.2%). The relative efficacy of pentobarbital in enhancing 36Cl- efflux among these various brain regions was highly correlated (r = 0.96, p 0.01) with the relative densities of [35S]-t-butylbicyclophosphorothionate-binding sites, a measure of GABA-gated Cl- channel density.(ABSTRACT TRUNCATED AT 250 WORDS)
在一种新型亚细胞脑制备物——突触神经小体中研究了膜氯(Cl-)通透性。使用放射性示踪剂交换技术,通过测量大鼠大脑皮质突触神经小体中36Cl-外流来确定Cl-转运。巴比妥类药物以剂量依赖性方式增加36Cl-外流,其效力的相对顺序如下:5-(1,3-二甲基丁基)-5-乙基巴比妥酸((-)-DMBB)大于戊巴比妥大于司可巴比妥大于(+)-DMBB大于己巴比妥大于异戊巴比妥大于美芬妥英。苯巴比妥和巴比妥实际上无活性。观察到这些巴比妥类药物刺激36Cl-外流的效力与其在小鼠中的麻醉效力(r = 0.90,p < 0.01)以及它们增强[3H]地西泮与脑膜结合的能力(r = 0.77,p < 0.05)之间有良好的相关性。戊巴比妥增强36Cl-外流的作用被γ-氨基丁酸(GABA)拮抗剂印防己毒素和荷包牡丹碱逆转。印防己毒素和荷包牡丹碱在无戊巴比妥时均降低36Cl-外流,提示存在内源性GABA。用阴离子转运抑制剂4,4'-二异硫氰酸根合或二硝基-2,2'-二磺酸芪孵育突触神经小体,也降低基础和戊巴比妥诱导的36Cl-外流。戊巴比妥(500 microM)在小脑、海马和皮质中诱导36Cl-外流最有效(分别为23.7%、23.6%和22.5%),而在纹状体(15.1%)和脑桥-延髓(6.2%)中刺激36Cl-外流的效果较差。戊巴比妥在这些不同脑区增强36Cl-外流的相对效力与[35S]-叔丁基双环磷硫代酸盐结合位点的相对密度高度相关(r = 0.96,p 0.01),[35S]-叔丁基双环磷硫代酸盐结合位点是GABA门控Cl-通道密度的一种度量。(摘要截短于250字)